azathioprine has been researched along with Infectious Myelitis in 8 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azathioprine was used as a maintenance treatment." | 2.66 | Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review. ( Anagnostouli, M; Andreadou, E; Boutzios, G; Evangelopoulos, ME; Fragoulis, GE; Kilidireas, C; Koutsis, G; Stefanis, L; Toulas, P; Tzanetakos, D; Tzartos, J; Vakrakou, AG; Velonakis, G, 2020) |
| "Myelitis was the most common attack type throughout the disease course (51." | 1.72 | The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China. ( Chang, X; Dong, Q; Huang, W; Li, W; Li, X; Lu, C; Lu, J; Quan, C; Tan, H; Wang, L; Wang, M; Xia, J; ZhangBao, J; Zhao, C; Zhou, L, 2022) |
| "An exacerbation of the myelitis, retinitis, encephalitis and colitis was observed and a cytomegalovirus infection diagnosed." | 1.31 | CMV complications in common variable immunodeficiency. ( Schmidt, RE; Werwitzke, S; Witte, T, 2000) |
| "A 26-year-old woman suffered from acute myelitis at Th 6 level associated with systemic lupus erythematosus." | 1.31 | Development of severe longitudinal atrophy of thoracic spinal cord following lupus-related myelitis. ( Kawagoe, J; Kawasaki, S; Matsukura, S; Ohi, T; Shiomi, K; Sugimoto, S; Yazawa, S, 2001) |
| "A case of transverse myelitis in a 16-year-old woman with mixed connective tissue disease is described." | 1.27 | Transverse myelitis in mixed connective tissue disease. ( Boesen, F; Bonen, H; Pedersen, C, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W | 1 |
| Tan, H | 1 |
| Xia, J | 1 |
| Li, W | 1 |
| Li, X | 1 |
| ZhangBao, J | 1 |
| Chang, X | 1 |
| Wang, L | 1 |
| Wang, M | 1 |
| Zhao, C | 1 |
| Lu, J | 1 |
| Lu, C | 1 |
| Dong, Q | 1 |
| Zhou, L | 1 |
| Quan, C | 1 |
| Vakrakou, AG | 1 |
| Evangelopoulos, ME | 1 |
| Boutzios, G | 1 |
| Tzanetakos, D | 1 |
| Tzartos, J | 1 |
| Velonakis, G | 1 |
| Toulas, P | 1 |
| Anagnostouli, M | 1 |
| Andreadou, E | 1 |
| Koutsis, G | 1 |
| Stefanis, L | 1 |
| Fragoulis, GE | 1 |
| Kilidireas, C | 1 |
| Moskau, S | 1 |
| Urbach, H | 1 |
| Hartmann, A | 1 |
| Schmidt, S | 1 |
| Shimizu, Y | 1 |
| Yokoyama, K | 1 |
| Misu, T | 1 |
| Takahashi, T | 1 |
| Fujihara, K | 1 |
| Kikuchi, S | 1 |
| Itoyama, Y | 1 |
| Iwata, M | 1 |
| Witte, T | 1 |
| Werwitzke, S | 1 |
| Schmidt, RE | 1 |
| Larner, AJ | 1 |
| Farmer, SF | 1 |
| Yazawa, S | 1 |
| Kawasaki, S | 1 |
| Ohi, T | 1 |
| Shiomi, K | 1 |
| Sugimoto, S | 1 |
| Kawagoe, J | 1 |
| Matsukura, S | 1 |
| Pedersen, C | 1 |
| Bonen, H | 1 |
| Boesen, F | 1 |
1 review available for azathioprine and Infectious Myelitis
| Article | Year |
|---|---|
Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review.
Topics: Adolescent; Asymptomatic Diseases; Autoimmune Hypophysitis; Azathioprine; Cervical Vertebrae; Female | 2020 |
7 other studies available for azathioprine and Infectious Myelitis
| Article | Year |
|---|---|
The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China.
Topics: Antibodies, Antinuclear; Aquaporin 4; Autoantibodies; Azathioprine; Female; Humans; Iodide Peroxidas | 2022 |
Multifocal myelitis in Behçet's disease.
Topics: Adult; Azathioprine; Behcet Syndrome; HLA-B Antigens; HLA-B51 Antigen; Humans; Magnetic Resonance Im | 2003 |
Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis.
Topics: Adult; Azathioprine; Brain; Brain Diseases; Female; Humans; Immunosuppressive Agents; Interferon Typ | 2008 |
CMV complications in common variable immunodeficiency.
Topics: Adult; Antiviral Agents; Azathioprine; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lym | 2000 |
Myelopathy following influenza vaccination in inflammatory CNS disorder treated with chronic immunosuppression.
Topics: Adult; Azathioprine; Brain; Brown-Sequard Syndrome; Cervical Vertebrae; Drug Interactions; Humans; I | 2000 |
Development of severe longitudinal atrophy of thoracic spinal cord following lupus-related myelitis.
Topics: Adult; Atrophy; Azathioprine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Ery | 2001 |
Transverse myelitis in mixed connective tissue disease.
Topics: Adolescent; Azathioprine; Drug Therapy, Combination; Female; Humans; Mixed Connective Tissue Disease | 1987 |